2025
|
Invention
|
Method for treating insulin resistance, enhancing insulin sensitivity, providing glycemic control... |
2024
|
G/S
|
Bacteriostats for veterinary purposes; medicines for human purposes, namely, medicines for treatm... |
2023
|
Invention
|
Pyrimidine amide compounds and use thereof. 122 is defined herein. Also disclosed is a method for... |
2021
|
Invention
|
Pharmaceutical composition and use thereof.
Disclosed is a pharmaceutical composition comprising... |
|
Invention
|
Processes for producing amide compounds, and their crystalline and salt form. Disclosed is proces... |
|
Invention
|
Processes for producing amide compounds, and their crystalline and salt form. Discloased is proce... |
|
Invention
|
Pharmaceutical composition and use thereof.
An oral pharmaceutical formulation containing an eff... |
|
Invention
|
Pharmaceutical composition and use thereof. Discloased is a pharmaceutical composition comprising... |
2020
|
Invention
|
Pyrimidine amide compounds and use thereof.
Disclosed are compounds of formula (I) below or a st... |
|
Invention
|
Pyrimidine amide compounds and use thereof. 121233 and n is defined herein. Also disclosed is a m... |
2018
|
Invention
|
Compound and pharmaceutical composition containing the same. 3 is defined herein. Also disclosed ... |
|
Invention
|
Novel compound and pharmaceutical composition containing the same. 341233 is defined herein. Also... |
|
Invention
|
Amide compounds and use thereof. 2, L, and Z is defined herein. Also disclosed are methods for re... |
|
Invention
|
Amide compounds and use thereof. 4, X and Y is defined herein. Also disclosed are methods for red... |
|
Invention
|
Amide compounds and use thereof. Disclosed are compounds of formula (I) below and pharmaceuticall... |